{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T19:16:07Z","timestamp":1775589367923,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008340","name":"Elsass Fonden","doi-asserted-by":"publisher","award":["19-3-0531"],"award-info":[{"award-number":["19-3-0531"]}],"id":[{"id":"10.13039\/501100008340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["15869"],"award-info":[{"award-number":["15869"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008397","name":"Velux Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bone.2020.115692","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T03:39:43Z","timestamp":1602733183000},"page":"115692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice"],"prefix":"10.1016","volume":"142","author":[{"given":"Mikkel Bo","family":"Brent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Lodberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik Duch","family":"Bromer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bram C.J.","family":"van der Eerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Eijken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie","family":"Br\u00fcel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Skovhus","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2020.115692_bb0005","first-page":"79","article-title":"Neuromuscular dysfunction, independent of gait dysfunction, modulates trabecular bone homeostasis in mice","volume":"19","author":"Bain","year":"2019","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2020.115692_bb0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s007740050093","article-title":"Effects of sciatic neurectomy on the femur in growing rats: application of peripheral quantitative computed tomography and Fourier transform infrared spectroscopy","volume":"17","author":"Yonezu","year":"1999","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2020.115692_bb0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00198-005-2028-8","article-title":"Osteoporosis after spinal cord injury","volume":"17","author":"Jiang","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115692_bb0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.sc.3101125","article-title":"Results from bone mineral density scans in twenty-two complete lesion paraplegics","volume":"39","author":"Wood","year":"2001","journal-title":"Spinal Cord"},{"key":"10.1016\/j.bone.2020.115692_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bonr.2015.04.001","article-title":"Immobilization induced osteopenia is strain specific in mice","volume":"2","author":"Lodberg","year":"2015","journal-title":"Bone Reports."},{"key":"10.1016\/j.bone.2020.115692_bb0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bone.2018.02.017","article-title":"PTH (1\u201334) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats","volume":"110","author":"Brent","year":"2018","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bone.2014.06.020","article-title":"Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats","volume":"66","author":"Vegger","year":"2014","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S8756-3282(00)00438-5","article-title":"Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin","volume":"28","author":"Chappard","year":"2001","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02555744","article-title":"Bone remodeling during the development of osteoporosis in paraplegia","volume":"38","author":"Chantraine","year":"1986","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115692_bb0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s001980200077","article-title":"Quantitative ultrasound assessment of acute bone loss following spinal cord injury: a longitudinal pilot study","volume":"13","author":"Warden","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115692_bb0055","series-title":"Pharmacological Mechanisms of Therapeutics: Parathyroid Hormone, in: Princ","first-page":"1659","author":"Hanley","year":"2008"},{"key":"10.1016\/j.bone.2020.115692_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.berh.2007.11.006","article-title":"Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations","volume":"22","author":"Egbuna","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bone.2020.115692_bb0065","doi-asserted-by":"crossref","first-page":"50259","DOI":"10.1074\/jbc.M307444200","article-title":"Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts: a putative explanation for why intermittent administration is needed for bone anabolism","volume":"278","author":"Bellido","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115692_bb0070","doi-asserted-by":"crossref","first-page":"19374","DOI":"10.1074\/jbc.M108913200","article-title":"Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells","volume":"277","author":"Chen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115692_bb0075","first-page":"18","article-title":"The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics","volume":"34","author":"Lombardi","year":"2011","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.bone.2020.115692_bb0080","doi-asserted-by":"crossref","unstructured":"R. Zhang, J.R. Edwards, S.Y. Ko, S. Dong, H. Liu, B.O. Oyajobi, C. Papasian, H.W. Deng, M. Zhao, Transcriptional regulation of BMP2 expression by the PTH-CREB signaling pathway in osteoblasts, PLoS One. 6 (2011).","DOI":"10.1371\/journal.pone.0020780"},{"key":"10.1016\/j.bone.2020.115692_bb0085","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cellsig.2009.02.012","article-title":"PTH and PTHrP signaling in osteoblasts","volume":"21","author":"Datta","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bone.2020.115692_bb0090","doi-asserted-by":"crossref","first-page":"s307","DOI":"10.1111\/j.1365-2265.1976.tb03839.x","article-title":"Chemistry and physiology of parathyroid hormone","volume":"5","author":"Potts","year":"1976","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2020.115692_bb0095","series-title":"Physiological Roles for Parathyroid Hormone-Related Protein: Lessons from Gene Knockout Mice, in: Vitam","first-page":"177","author":"Karaplis","year":"1996"},{"key":"10.1016\/j.bone.2020.115692_bb0100","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/endo-103-3-978","article-title":"Human parathyroid hormone: synthesis and chemical, biological, and immunological evaluation of the carboxyl-terminal region","volume":"103","author":"Rosenblatt","year":"1978","journal-title":"Endocrinology."},{"key":"10.1016\/j.bone.2020.115692_bb0105","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1016\/S0021-9258(18)37641-5","article-title":"Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. Binding to parathyroid hormone receptors and activation of adenylate cyclase in bone cells and kidney","volume":"263","author":"Nissenson","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115692_bb0110","doi-asserted-by":"crossref","unstructured":"L. Harlow, K. Sahbani, J.S. Nyman, C.P. Cardozo, W.A. Bauman, H.A. Tawfeek, Daily parathyroid hormone administration enhances bone turnover and preserves bone structure after severe immobilization-induced bone loss, Physiol. Rep. 5 (2017).","DOI":"10.14814\/phy2.13446"},{"key":"10.1016\/j.bone.2020.115692_bb0115","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1359\/jbmr.1999.14.10.1691","article-title":"Intermittent administration of human parathyroid hormone(1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice","volume":"14","author":"Sakai","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115692_bb0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s007760200063","article-title":"Comparative effects of intermittent administration of human parathyroid hormone (1-34) on cancellous and cortical bone loss in tail-suspended and sciatic neurectomized young rats","volume":"7","author":"Moriyama","year":"2002","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.bone.2020.115692_bb0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MED.0b013e32831a46d6","article-title":"Parathyroid hormone treatment for osteoporosis","volume":"15","author":"Cosman","year":"2008","journal-title":"Curr. Opin. Endocrinol. Diabetes. Obes."},{"key":"10.1016\/j.bone.2020.115692_bb0130","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.3525","article-title":"Effects of teriparatide and vibration on bone mass and bone strength in people with bone loss and spinal cord injury: a randomized, controlled trial","volume":"33","author":"Edwards","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115692_bb0135","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2020.115692_bb0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.pmrj.2013.03.032","article-title":"Effect of parathyroid hormone combined with gait training on bone density and bone architecture in people with chronic spinal cord injury","volume":"5","author":"Gordon","year":"2013","journal-title":"PM R."},{"key":"10.1016\/j.bone.2020.115692_bb0145","doi-asserted-by":"crossref","first-page":"13809","DOI":"10.1074\/jbc.M117.782128","article-title":"Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass","volume":"292","author":"Goh","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115692_bb0150","first-page":"E5266","article-title":"Specific targeting of TGF-\u03b2 family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2020.115692_bb0155","doi-asserted-by":"crossref","unstructured":"E. Latres, J. Mastaitis, W. Fury, L. Miloscio, J. Trejos, J. Pangilinan, H. Okamoto, K. Cavino, E. Na, A. Papatheodorou, T. Willer, Y. Bai, J.H. Kim, A. Rafique, S. Jaspers, T. Stitt, A.J. Murphy, G.D. Yancopoulos, J. Gromada, Activin A more prominently regulates muscle mass in primates than does GDF8, Nat. Commun. 8 (2017).","DOI":"10.1038\/ncomms15153"},{"key":"10.1016\/j.bone.2020.115692_bb0160","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1096\/fj.201801969RR","article-title":"A follistatin-based molecule increases muscle and bone mass without affecting the red blood cell count in mice","volume":"33","author":"Lodberg","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2020.115692_bb0165","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1073\/pnas.0711263105","article-title":"A soluble activin type IIA receptor induces bone formation and improves skeletal integrity","volume":"105","author":"Pearsall","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2020.115692_bb0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1874467211205020195","article-title":"Activin receptor signaling: a potential therapeutic target for osteoporosis","volume":"5","author":"Lotinun","year":"2012","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bone.2020.115692_bb0175","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bone.2018.02.026","article-title":"A soluble activin type IIA receptor mitigates the loss of femoral neck bone strength and cancellous bone mass in a mouse model of disuse osteopenia","volume":"110","author":"Lodberg","year":"2018","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bone.2017.02.009","article-title":"Parathyroid hormone\u2019s enhancement of bones\u2019 osteogenic response to loading is affected by ageing in a dose- and time-dependent manner","volume":"98","author":"Meakin","year":"2017","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115692_bb0190","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1210\/en.2004-1282","article-title":"Bone response to intermittent parathyroid hormone is altered in mice null for \u03b2-arrestin2","volume":"146","author":"Ferrari","year":"2005","journal-title":"Endocrinology."},{"key":"10.1016\/j.bone.2020.115692_bb0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1507\/endocrj.K09E-349","article-title":"Short-term intermittent PTH 1-34 administration enhances bone formation in SCID\/beige mice","volume":"57","author":"Sheehan","year":"2010","journal-title":"Endocr. J."},{"key":"10.1016\/j.bone.2020.115692_bb0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bone.2005.08.009","article-title":"Botox induced muscle paralysis rapidly degrades bone","volume":"38","author":"Warner","year":"2006","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0205","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"NC3Rs reporting guidelines working group, animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bone.2020.115692_bb0210","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00223-012-9576-7","article-title":"Loss of bone strength is dependent on skeletal site in disuse osteoporosis in rats","volume":"90","author":"Thomsen","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115692_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bonr.2017.12.001","article-title":"The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice","volume":"8","author":"Brent","year":"2018","journal-title":"Bone Reports."},{"key":"10.1016\/j.bone.2020.115692_bb0220","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115692_bb0225","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115692_bb0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00774-017-0830-y","article-title":"Disuse osteopenia induced by botulinum toxin is similar in skeletally mature young and aged female C57BL\/6J mice","volume":"36","author":"Vegger","year":"2018","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2020.115692_bb0235","first-page":"355","article-title":"Alterations in gene expression precede sarcopenia and osteopenia in botulinum toxin immobilized mice","volume":"16","author":"Vegger","year":"2016","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2020.115692_bb0240","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An antibody blocking Activin Type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy","volume":"34","author":"Lach-Trifilieff","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bone.2020.115692_bb0245","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1210\/en.2004-0770","article-title":"The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone","volume":"146","author":"Knopp","year":"2005","journal-title":"Endocrinology."},{"key":"10.1016\/j.bone.2020.115692_bb0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jbmr.5650070110","article-title":"Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone","volume":"7","author":"Hock","year":"1992","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115692_bb0255","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/JBMR.040808","article-title":"Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells","volume":"19","author":"Tanaka","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115692_bb0260","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S8756-3282(03)00057-7","article-title":"Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice","volume":"32","author":"Zhou","year":"2003","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0265","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jbmr.5650100322","article-title":"Human parathyroid hormone-(1\u201338) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats","volume":"10","author":"Ma","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115692_bb0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/bulm.1999.0146","article-title":"Parathyroid hormone temporal effects on bone formation and resorption","volume":"62","author":"Kroll","year":"2000","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.bone.2020.115692_bb0275","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/BMM:4:4:233","article-title":"Parathyroid hormone and bone cells","volume":"4","author":"Murrills","year":"2006","journal-title":"Clin. Rev. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2020.115692_bb0280","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation byprevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2020.115692_bb0285","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1359\/jbmr.2003.18.3.561","article-title":"Tail suspension induces bone loss in skeletally mature mice in the C57Bl\/6J strain but not in the C3H\/HeJ strain","volume":"18","author":"Amblard","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115692_bb0290","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00223-013-9814-7","article-title":"Combined effects of botulinum toxin injection and hind limb unloading on bone and muscle","volume":"94","author":"Ellman","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115692_bb0295","doi-asserted-by":"crossref","unstructured":"M.A. Heffner, D.C. Genetos, B.A. Christiansen, Bone adaptation to mechanical loading in a mouse model of reduced peripheral sensory nerve function, PLoS One. 12 (2017).","DOI":"10.1371\/journal.pone.0187354"},{"key":"10.1016\/j.bone.2020.115692_bb0300","doi-asserted-by":"crossref","unstructured":"T. Matsumoto, K. Nakayama, Y. Kodama, H. Fuse, T. Nakamura, S. Fukumoto, Effect of mechanical unloading and reloading on periosteal bone formation and gene expression in tail-suspended rapidly growing rats, in: Bone, Elsevier Inc., 1998: pp. 89S\u201393S.","DOI":"10.1016\/S8756-3282(98)00018-0"},{"key":"10.1016\/j.bone.2020.115692_bb0305","unstructured":"J.M. Hock, Anabolic actions of PTH in the skeletons of animals., 2001."},{"key":"10.1016\/j.bone.2020.115692_bb0310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00223-018-0471-8","article-title":"Longitudinal examination of bone loss in male rats after moderate\u2013severe contusion spinal cord injury","volume":"104","author":"Otzel","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115692_bb0315","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bone.2013.01.018","article-title":"Paradoxical Sost gene expression response to mechanical unloading in metaphyseal bone","volume":"53","author":"Macias","year":"2013","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0320","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7150\/ijms.11078","article-title":"Paradoxical response to mechanical unloading in bone loss, microarchitecture, and bone turnover markers","volume":"12","author":"Sun","year":"2015","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bone.2020.115692_bb0325","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1074\/jbc.M114.628313","article-title":"The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in vitro","volume":"290","author":"Spatz","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115692_bb0330","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s00198-016-3700-x","article-title":"Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury","volume":"27","author":"Qin","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2020.115692_bb0335","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0340","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S8756-3282(00)00276-3","article-title":"Parathyroid hormone and growth hormone have additive or synergetic effect when used as intervention treatment in ovariectomized rats with established osteopenia","volume":"26","author":"Mosekilde","year":"2000","journal-title":"Bone."},{"key":"10.1016\/j.bone.2020.115692_bb0345","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1196\/annals.1402.009","article-title":"Bone loss after temporarily induced muscle paralysis by Botox is not fully recovered after 12 weeks","volume":"1116","author":"Grimston","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2020.115692_bb0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1507\/endocrj.KR-110","article-title":"Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer","volume":"55","author":"Tsuchida","year":"2008","journal-title":"Endocr. J."},{"key":"10.1016\/j.bone.2020.115692_bb0355","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1043-2760(00)00294-0","article-title":"Activin signal transduction pathways","volume":"11","author":"Pangas","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bone.2020.115692_bb0360","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","article-title":"How cells read TGF-\u03b2 signals","volume":"1","author":"Massagu\u00e9","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bone.2020.115692_bb0365","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1046\/j.1432-1327.2000.01828.x","article-title":"Signaling of transforming growth factor-\u03b2 family members through Smad proteins","volume":"267","author":"Itoh","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bone.2020.115692_bb0370","doi-asserted-by":"crossref","first-page":"33086","DOI":"10.1074\/jbc.M705194200","article-title":"Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2020.115692_bb0375","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/13543784.2015.973021","article-title":"Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis","volume":"24","author":"Polyzos","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bone.2020.115692_bb0380","doi-asserted-by":"crossref","unstructured":"M.P. Yavropoulou, A. Michopoulos, J.G. Yovos, PTH and PTHR1 in osteocytes. New insights into old partners, Hormones. 16 (2017) 150\u2013160.","DOI":"10.14310\/horm.2002.1730"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220304725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:50:36Z","timestamp":1757613036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220304725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":76,"alternative-id":["S8756328220304725"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115692","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115692"}}